Philip Grossen

Philip Grossen is a Senior Scientist in the Pharmaceutical Development department at F.Hoffmann-La Roche Ltd. He is a Pharmaceutical Project Lead for gene therapy programs and scientist in vector formulation and process development. Prior to his current position, he led drug product development activities of clinical stage cell therapy programs and lentiviral vectors. Philip holds a Ph.D. in Pharmaceutical Technology from the University of Basel. His doctoral and postdoctoral research projects focused on development of non-viral gene delivery systems, oncolytic viruses, extracellular vesicles and oral delivery of oligonucleotides.